Brief rapamycin therapy in middle-aged mice extends lives

Quicklink Submitted By Scott Baker 3 comments

Managing Editor
Scott Baker

Become a Fan
(78 fans)

Elife - Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice.
(Image by Next Big Future) Details DMCA

In mice, the drug rapamycin is known to extend lives and delay some age-related problems. Questions remain about about how it promotes healthy aging, when, how much and how long to administer rapamycin, and how to avoid serious side effects. A new study showed brief therapy during middle age with rapamycin dramatically extended mouse lives. Findings revealed the need to further examine how gender and dose influence side effects and the drug's impact on susceptibility to and protection from different types of cancer.

Read the rest of the story HERE:

At www.eurekalert.org

1
Rate It | View Ratings

Scott Baker Social Media Pages:

Scott Baker is a Managing Editor & The Economics Editor at Opednews, and a former blogger for Huffington Post, Daily Kos, and Global Economic Intersection.

His anthology of updated Opednews articles "America is Not Broke" was published by Tayen Lane Publishing (March, 2015) and may be found here:
http://www.americaisnotbroke.net/

Scott is a former and current President of Common Ground-NY (http://commongroundnyc.org/), a Geoist/Georgist activist group. He has written dozens of (more...)